Patrick Thomas, an undergraduate cancer researcher in Dr. Laura Gibson's lab, was the winner in the Health Sciences category of the 2017 Summer Undergraduate Research Symposium (SURE).
Congratulations to our Bone Marrow Transplant (BMT) team! The Cigna LifeSOURCE Transplant Network has rated the WVU Cancer Institute Osborn Hematopoietic Malignancy and Transplantation Program a Program of Excellence once again. Cigna, an insurance company WVU contracts with that allows patients to be transplanted at our facility, based the excellence designation on specific criteria and guidelines, including number and types of transplants, patient survival and disease status. “This validates that our program provides superior care,” says Sonia Leadmon, oncology quality coordinator at the Cancer Institute’s Mary Babb Randolph Cancer Center. WVU has been rated a Cigna Program of Excellence every year since 2014 and has received excellence designations from several other insurance companies for its BMT program.
Patrick Thomas, an undergraduate cancer researcher in Dr. Laura Gibson's lab, was the winner in the Health Sciences category of the 2017 Summer Undergraduate Research Symposium (SURE).
Gordon Smith, M.D., MPH, Stuart M. and Joyce N. Robbins Distinguished Professor at the WVU School of Public Health, and Judith Feinberg, M.D., of the WVU School of Medicine, are co-leading a project that will develop an integrated prevention, harm reduction and treatment team to rapidly identify and mitigate small HIV microepidemics.
Congratulations to the WVU Clinical trials Research Unit (CTRU) and Dr. Adham Salkeni, WVU’s principal investigator for the NRG Oncology group, the largest clinical trials collaborative network in the United States. During the recent biannual meeting of the NRG, our CTRU was recognized as among the top ten main member sites to enroll the most patients on cancer clinical trials between January and June 2017. “This places WVU on the national map for clinical trials accrual,” Salkeni said. “This shows that we offer state-of-the-art research studies that examine the role of targeted therapies for the treatment of a wide variety of cancers that affect our patient population.”
Cancer Prevention and Control (CPC) program staff won two first place ribbons at the 2017 Centers for Disease Control and Prevention National Cancer Conference in Atlanta this August. They were invited to present three posters for the overall National conference and an oral presentation for the CDC Colorectal Cancer Control Program Meeting. Two posters, noted below, won first place ribbons.
The Women’s Golf Association at the Parkersburg Country Club is helping the WVU Cancer Institute win the fight against breast cancer. During its Annual Golf Fore A Cure Invitational on June 14 the Association raised more than $12,000 for breast cancer research at the Cancer Institute in Morgantown and to support Camden Clark Foundation’s Pink Mammogram Fund, which provides free screening mammograms, diagnostics and breast biopsies for local underinsured and uninsured residents at the Cancer Institute’s Camden Clark Medical Center. Proceeds from the Invitational came from participant entry fees, hole sponsorships, doorprize tickets and mulligans sold the day of the event. “A lot of our members have either been treated or are being treated for breast cancer at the WVU Cancer Institute and we like to support local efforts to fight the disease,” said Sue Lilly, who co-chaired Golf Fore A Cure with Judy Crichton.
MORGANTOWN, W.Va. – Richard M. Goldberg, M.D., renowned gastrointestinal cancer expert, has been named the new director of the WVU Cancer Institute.
Earlier this year when Mary J.C. Hendrix was named president of Shepherd University, she had a critical decision to make: To shut down her research laboratory at Northwestern University or relocate her groundbreaking cancer research closer to Shepherd. The answer came in a unique partnership with West Virginia University, a major R1 research university 150 miles to the west of Shepherd. Thanks to sophisticated Skype technology, Hendrix and her laboratory are able to resume daily research interactions.
